# The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection

> **NCT02896413** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 100 (actual)

## Conditions studied

- Uterine Cancer

## Interventions

- **DRUG:** Dexmedetomidine group
- **DRUG:** Control group

## Key facts

- **NCT ID:** NCT02896413
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-02
- **Primary completion:** 2018-10-24
- **Final completion:** 2018-10-24
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896413, "The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02896413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*